A HITHERTO infrequently recognized abnormality in patients with osteoblastic metastases is the occurrence of hypocalcemia. It has usually been held that calcium levels are normal in this situation. 1 ...

The US Food and Drug Administration (FDA) has added a boxed warning to the label of the osteoporosis drug denosumab (Prolia) about increased risk for severe hypocalcemia in patients with advanced ...

Please provide your email address to receive an email when new articles are posted on . The FDA issued a boxed warning stating denosumab increases severe hypocalcemia risk for adults with advanced CKD ...

Background A 70-year-old man presented with a smooth lump on his buccal mucosa and right-sided cervical lymphadenopathy. Staging investigations revealed extensive sclerotic bone metastases and the ...

The use of the osteoporosis drug denosumab (Prolia) to prevent fractures associated with advanced chronic kidney disease (CKD) in patients on kidney dialysis significantly increases the risk for ...

The FDA said it's looking into the risk of severe hypocalcemia among patients on dialysis receiving denosumab (Prolia), citing the potential for severe outcomes, including hospitalization and death.

Blanket routine calcium supplementation after thyroidectomy was no more effective than selective, parathyroid hormone (PTH)-guided therapy for preventing hypocalcemia in a randomized trial. The ...

Real-World Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With First-Line Nivolumab Plus Ipilimumab in the United States Denosumab is widely used in the treatment of bone metastases ...

Whenever we hear the word calcium, most of us associate it with strong bones and healthy teeth. Having strong bones and healthy teeth is translated as an indication of having enough calcium in your ...